Stock Research: Balchem

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Balchem

NasdaqGS:BCPC US0576652004
76
  • Value
    71
  • Growth
    47
  • Safety
    Safety
    42
  • Combined
    53
  • Sentiment
    98
  • 360° View
    360° View
    76
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. It operates in the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets. It operates in the Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products segments. In the last fiscal year, the company had a market cap of $5,124 million, profits of $336 million, revenue of $954 million, and 1361 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Balchem are very positive. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Balchem. The consolidated Sentiment Rank has a good rank of 98, which means that professional investors are more optimistic about the stock than for 98% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 71 or better than 71% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 42, meaning that the share price of Balchem is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 47. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 4-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 41 43 37
Growth
47 53 33 31
Safety
Safety
71 53 53 80
Sentiment
98 90 72 86
360° View
360° View
76 74 47 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
80 74 50 27
Opinions Change
93 50 50 50
Pro Holdings
n/a 92 62 90
Market Pulse
93 61 71 94
Sentiment
98 90 72 86
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 41 43 37
Growth
47 53 33 31
Safety Safety
71 53 53 80
Combined
53 47 29 52
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
31 26 23 18
Price vs. Earnings (P/E)
22 17 20 22
Price vs. Book (P/B)
27 21 24 14
Dividend Yield
82 86 84 86
Value
42 41 43 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
50 46 40 39
Profit Growth
53 46 39 43
Capital Growth
41 41 25 17
Stock Returns
39 63 69 83
Growth
47 53 33 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
66 56 51 69
Refinancing
23 20 23 15
Liquidity
84 77 82 94
Safety Safety
71 53 53 80

Similar Stocks

Discover high‑ranked alternatives to Balchem and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.